Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2018

29.03.2017 | Original Article

Inducing Apoptosis and Decreasing Cell Proliferation in Human Acute Promyelocytic Leukemia Through Regulation Expression of CASP3 by Let-7a-5p Blockage

verfasst von: Mahdi Fasihi-Ramandi, Abbas Moridnia, Ali Najafi, Mohammadreza Sharifi

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs (miRNAs) are short and single strand non-coding RNAs that involved in post-transcriptional regulation of gene expression. Dysregulation of miRNA expression is important event in the many of malignant diseases. Up-regulation of Let-7a-5p expression in acute myeloid leukemia in human in previous studies was reported. In this study blockage of Let-7a-5p in human acute promyelocytic leukemia cell line (HL60) was done by using locked nucleic acid (LNA) method and subsequently expression of Let-7a-5p, cell proliferation, apoptosis, necrosis, and CASP3 expression was measured. At three time points 24, 48 and 72 h after LNA anti- Let-7a-5p transfection, assessment of Let-7a-5p expression by qRT real-time PCR was completed. The MTT assay and annexin/PI staining have been performed. Also, CASP3 expression at different time points after LNA anti-Let-7a-5p transfection in HL60 cell line was measured. The results at three-time points after LNA transfection were represented that Let-7a-5p expression was lower in the LNA-anti-Let-7a group compared to the control groups. The cell viability significantly was different between LNA-anti-Let-7a group and control groups. Increasing apoptotic ratio was associated with Let-7a-5p blockage in the LNA-anti-Let-7a group compared with control groups. Also, the necrotic ratio was higher in the LNA-anti-Let-7a group rather than the other groups. Western blotting revealed that CASP3 expression associated with Let-7a-5p inhibition. Our results displayed that blockage of Let-7a-5p can reduced cell viability mainly due to the induction of apoptosis and CASP3 up-regulation in HL60 cells. These results can be useful in translational medicine for research of antisense therapy in leukemia.
Literatur
1.
Zurück zum Zitat Randolph TR (2000) Acute promyelocytic Leukemia (AML-M3)-part 1: pathophysiology, clinical diagnosis, and differentiation therapy. Clin Lab Sci 13(2):98–105PubMed Randolph TR (2000) Acute promyelocytic Leukemia (AML-M3)-part 1: pathophysiology, clinical diagnosis, and differentiation therapy. Clin Lab Sci 13(2):98–105PubMed
2.
Zurück zum Zitat Borrow J, Goddard AD, Sheer D, Solomon E (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249(4976):1577–1580CrossRefPubMed Borrow J, Goddard AD, Sheer D, Solomon E (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249(4976):1577–1580CrossRefPubMed
3.
Zurück zum Zitat Dong C, Ji M, Ji C (2009) Micro-RNAs and their potential target genes in leukemia pathogenesis. Cancer Biol Ther 8(3):200–205CrossRefPubMed Dong C, Ji M, Ji C (2009) Micro-RNAs and their potential target genes in leukemia pathogenesis. Cancer Biol Ther 8(3):200–205CrossRefPubMed
4.
5.
Zurück zum Zitat Drakaki A, Iliopoulos D (2009) MicroRNA gene networks in oncogenesis. Curr Genom 10(1):35–41CrossRef Drakaki A, Iliopoulos D (2009) MicroRNA gene networks in oncogenesis. Curr Genom 10(1):35–41CrossRef
6.
Zurück zum Zitat Fabbri M, Garzon R, Andreeff M, Kantarjian H, Garcia-Manero G, Calin G (2008) MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 22(6):1095–1105CrossRefPubMed Fabbri M, Garzon R, Andreeff M, Kantarjian H, Garcia-Manero G, Calin G (2008) MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 22(6):1095–1105CrossRefPubMed
7.
Zurück zum Zitat Pelosi E, Labbaye C, Testa U (2009) MicroRNAs in normal and malignant myelopoiesis. Leuk Res 33(12):1584–1593CrossRefPubMed Pelosi E, Labbaye C, Testa U (2009) MicroRNAs in normal and malignant myelopoiesis. Leuk Res 33(12):1584–1593CrossRefPubMed
8.
Zurück zum Zitat Yendamuri S, Calin G (2009) The role of microRNA in human leukemia: a review. Leukemia 23(7):1257–1263CrossRefPubMed Yendamuri S, Calin G (2009) The role of microRNA in human leukemia: a review. Leukemia 23(7):1257–1263CrossRefPubMed
9.
Zurück zum Zitat Schotte D, Chau J, Sylvester G, Liu G, Chen C, van der Velden V et al (2009) Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 23(2):313–322CrossRefPubMed Schotte D, Chau J, Sylvester G, Liu G, Chen C, van der Velden V et al (2009) Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 23(2):313–322CrossRefPubMed
10.
Zurück zum Zitat Li Y, Lin J, Yang J, Qian J, Qian W, D-m Yao et al (2013) Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia. Leuk Res 37(12):1642–1647CrossRefPubMed Li Y, Lin J, Yang J, Qian J, Qian W, D-m Yao et al (2013) Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia. Leuk Res 37(12):1642–1647CrossRefPubMed
11.
Zurück zum Zitat Tsang WP, Kwok TT (2008) Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 13(10):1215–1222CrossRefPubMed Tsang WP, Kwok TT (2008) Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 13(10):1215–1222CrossRefPubMed
12.
Zurück zum Zitat Zamore PD, Haley B (2005) Ribo-gnome: the big world of small RNAs. Science 309(5740):1519–1524CrossRefPubMed Zamore PD, Haley B (2005) Ribo-gnome: the big world of small RNAs. Science 309(5740):1519–1524CrossRefPubMed
13.
Zurück zum Zitat Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120(5):635–647CrossRefPubMed Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120(5):635–647CrossRefPubMed
14.
Zurück zum Zitat Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D et al (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Can Res 67(16):7713–7722CrossRef Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D et al (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Can Res 67(16):7713–7722CrossRef
16.
17.
Zurück zum Zitat Ørom UA, Kauppinen S, Lund AH (2006) LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 372:137–141CrossRefPubMed Ørom UA, Kauppinen S, Lund AH (2006) LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 372:137–141CrossRefPubMed
18.
Zurück zum Zitat Sharifi M, Salehi R (2015) Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia. Cancer Gene Ther 23:29–35CrossRefPubMed Sharifi M, Salehi R (2015) Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia. Cancer Gene Ther 23:29–35CrossRefPubMed
19.
Zurück zum Zitat Airiau K, Prouzet-Mauléon V, Rousseau B, Pigneux A, Jeanneteau M, Giraudon M et al (2016) Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells. Oncotarget 7(1):845–859CrossRefPubMed Airiau K, Prouzet-Mauléon V, Rousseau B, Pigneux A, Jeanneteau M, Giraudon M et al (2016) Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells. Oncotarget 7(1):845–859CrossRefPubMed
20.
Zurück zum Zitat Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C et al (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci 105(10):3945–3950CrossRefPubMedPubMedCentral Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C et al (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci 105(10):3945–3950CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Whitman SP, Maharry K, Radmacher MD, Becker H, Mrózek K, Margeson D et al (2010) FLT3 internal tandem duplication associates with adverse outcome and gene-and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood 116(18):3622–3626CrossRefPubMedPubMedCentral Whitman SP, Maharry K, Radmacher MD, Becker H, Mrózek K, Margeson D et al (2010) FLT3 internal tandem duplication associates with adverse outcome and gene-and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood 116(18):3622–3626CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat O’Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D (2010) MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci 107(32):14235–14240CrossRefPubMedPubMedCentral O’Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D (2010) MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci 107(32):14235–14240CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Han Y-C, Park CY, Bhagat G, Zhang J, Wang Y, Fan J-B et al (2010) microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 207(3):475–489CrossRefPubMedPubMedCentral Han Y-C, Park CY, Bhagat G, Zhang J, Wang Y, Fan J-B et al (2010) microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 207(3):475–489CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Wallace J, Hu R, Mosbruger TL, Dahlem TJ, Stephens WZ, Rao DS et al (2016) Genome-wide CRISPR-Cas9 screen identifies MicroRNAs that regulate myeloid leukemia cell growth. PLoS ONE 11(4):e0153689CrossRefPubMedPubMedCentral Wallace J, Hu R, Mosbruger TL, Dahlem TJ, Stephens WZ, Rao DS et al (2016) Genome-wide CRISPR-Cas9 screen identifies MicroRNAs that regulate myeloid leukemia cell growth. PLoS ONE 11(4):e0153689CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A et al (2010) Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat Med 16(1):49–58CrossRefPubMed Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A et al (2010) Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat Med 16(1):49–58CrossRefPubMed
26.
Zurück zum Zitat Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci 99(24):15524–15529CrossRefPubMedPubMedCentral Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci 99(24):15524–15529CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Ola MS, Nawaz M, Ahsan H (2011) Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351(1–2):41–58CrossRefPubMed Ola MS, Nawaz M, Ahsan H (2011) Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351(1–2):41–58CrossRefPubMed
28.
Zurück zum Zitat Guan X, Liu Z, Liu H, Yu H, Wang L-E, Sturgis EM et al (2013) A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer. FASEB J 27(4):1404–1412CrossRefPubMedPubMedCentral Guan X, Liu Z, Liu H, Yu H, Wang L-E, Sturgis EM et al (2013) A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer. FASEB J 27(4):1404–1412CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Fesik SW (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5(11):876–885CrossRefPubMed Fesik SW (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5(11):876–885CrossRefPubMed
30.
Zurück zum Zitat Andersen MH, Becker JC, Thor Straten P (2005) Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat Rev Drug Discov 4(5):399–409CrossRefPubMed Andersen MH, Becker JC, Thor Straten P (2005) Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat Rev Drug Discov 4(5):399–409CrossRefPubMed
31.
Zurück zum Zitat Lee JW, Soung YH, Kim SY, Park WS, Nam SW, Lee JY et al (2006) Somatic mutation of pro-apoptosis caspase-6 gene is rare in breast and lung carcinomas. Pathology 38(4):358–359CrossRefPubMed Lee JW, Soung YH, Kim SY, Park WS, Nam SW, Lee JY et al (2006) Somatic mutation of pro-apoptosis caspase-6 gene is rare in breast and lung carcinomas. Pathology 38(4):358–359CrossRefPubMed
32.
Zurück zum Zitat Kania J, Konturek S, Marlicz K, Hahn E, Konturek P (2003) Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci 48(2):266–271CrossRefPubMed Kania J, Konturek S, Marlicz K, Hahn E, Konturek P (2003) Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci 48(2):266–271CrossRefPubMed
33.
Zurück zum Zitat Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY et al (2004) Somatic mutations of CASP3 gene in human cancers. Hum Genet 115(2):112–115CrossRefPubMed Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY et al (2004) Somatic mutations of CASP3 gene in human cancers. Hum Genet 115(2):112–115CrossRefPubMed
34.
Zurück zum Zitat Stoffel M, Poy MN, Tuschl TH (2015) MicroRNA and methods for inhibiting same. Google Patents Stoffel M, Poy MN, Tuschl TH (2015) MicroRNA and methods for inhibiting same. Google Patents
35.
Zurück zum Zitat Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4(3):143–159CrossRefPubMedPubMedCentral Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4(3):143–159CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Youk J, Koh Y, Park H, Kim D-Y, Lee C-S, Lee J et al (2014) Mutation in retinoic X receptor-γ is a possible mechanism of all-trans retinoic acid resistance in acute promyelocytic leukemia (APL): identifying genetic changes related to drug resistance in APL using whole exome sequencing. Blood 124(21):2358 Youk J, Koh Y, Park H, Kim D-Y, Lee C-S, Lee J et al (2014) Mutation in retinoic X receptor-γ is a possible mechanism of all-trans retinoic acid resistance in acute promyelocytic leukemia (APL): identifying genetic changes related to drug resistance in APL using whole exome sequencing. Blood 124(21):2358
Metadaten
Titel
Inducing Apoptosis and Decreasing Cell Proliferation in Human Acute Promyelocytic Leukemia Through Regulation Expression of CASP3 by Let-7a-5p Blockage
verfasst von
Mahdi Fasihi-Ramandi
Abbas Moridnia
Ali Najafi
Mohammadreza Sharifi
Publikationsdatum
29.03.2017
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 1/2018
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0809-9

Weitere Artikel der Ausgabe 1/2018

Indian Journal of Hematology and Blood Transfusion 1/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.